However, in early clinical trials, the long-term treatment of obese patients with supraphysiological doses of leptin has not confirmed the ability of recombinant leptin to act as an anti-obesity factor [52]. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.